Biomarker Discovery for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Using Untargeted Metabolomics and Lipidomics Studies

Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is the third leading cause of mortality globally. Patients with HCC have a poor prognosis due to the fact that the emergence of symptoms typically occurs at a late stage of the disease. In addition, conventional biomarkers perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Md Mamunur, Varghese, Rency S., Ding, Yuansong, Ressom, Habtom W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608999/
https://www.ncbi.nlm.nih.gov/pubmed/37887372
http://dx.doi.org/10.3390/metabo13101047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608999/
https://www.ncbi.nlm.nih.gov/pubmed/37887372
http://dx.doi.org/10.3390/metabo13101047

Ejemplares similares